Prnewswire
Search documents
JinkoSolar Announces Second and Third Quarter 2025 Financial Results
Prnewswire· 2025-11-17 12:04
Accessibility StatementSkip Navigation SHANGRAO, China, Nov. 17, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced its unaudited financial results for the second quarter ended June 30, 2025 and third quarter ended September 30, 2025. Third Quarter 2025 Business Highlights Third Quarter 2025 Operational and Financial Highlights Second Quarter 2025 Operational and Financ ...
Perpetua Resources Announces Third Quarter 2025 and Recent Highlights
Prnewswire· 2025-11-17 12:00
About Perpetua Resources and the Stibnite Gold Project Accessibility StatementSkip Navigation BOISE, Idaho, Nov. 17, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed consolidated financial results for the period ended September 30, 2025 were filed. For details, please see the Company's filings available on EDGAR and SEDAR. Perpetua Resources' vision is to provide the U.S. with a domestic ...
Freightos Reports Third Quarter 2025 Results
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation BARCELONA, Spain, Nov. 17, 2025 /PRNewswire/ --Â Freightos Limited (NASDAQ: CRGO), the leading vendor-neutral digital booking and payment platform for the international freight industry, today reported its financial results for the quarter ended September 30, 2025. "This quarter marks another consecutive period of record revenue and transactions for Freightos as we continue to demonstrate the resilience and growing adoption of our digital freight booking platform," sai ...
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation Halozyme Therapeutics, Inc. Logo. (PRNewsFoto/Halozyme Therapeutics, Inc.) (PRNewsfoto/Halozyme Therapeutics, Inc.) SAN DIEGO and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 17, 2025 /PRNewswire/ -- Merus N.V. (Nasdaq: MRUS) ("Merus"), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics, Triclonics and ADClonics), and Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme"), a leader in subcuta ...
Ceva Receives 2025 IoT Edge Computing Excellence Award from IoT Evolution World
Prnewswire· 2025-11-17 12:00
About Crossfire Media Crossfire Media, co-publishers of IoT Evolution, is an integrated marketing company with a core focus on future trends in technology. We service communities of interest with conferences, tradeshows, webinars and newsletters. Crossfire Media has a partnership with Technology Marketing Corporation (TMC) to produce events and websites related to disruptive technologies. Crossfire Media is a division of Crossfire Consulting, a full service Information Technology company based in New York. ...
Arbe Announces Q3 2025 Financial Results
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation TEL AVIV, Israel, Nov. 17, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE) ("Arbe," "we," "our" and the "Company"), a global leader in perception radar solutions, today announced its financial results and provided an investor update for its third quarter, ending September 30, 2025. Recent Highlights Management Comment "We made strong strategic progress in the third quarter," said Kobi Marenko, Chief Executive Officer of Arbe Robotics. "Our evaluat ...
Quantum Computing Inc. to Unveil Photonics-Based Reservoir Computer, Neurawave, at SuperCompute25
Prnewswire· 2025-11-17 12:00
Neurawave represents a significant milestone for QCi as it delivers a photonic computing system designed to meet industry standards and seamlessly integrates with existing computing infrastructures. Built in a standard PCIe interface, Neurawave combines cutting-edge optical computing with digital electronics to offer a practical, scalable, and energy-efficient solution for high-performance applications. Operating fully at room temperature with a compact design, Neurawave brings QCi's technology roadmap into ...
Protiviti Congratulates Brand Ambassador Matt Fitzpatrick on Victory at the DP World Tour Championship
Prnewswire· 2025-11-17 12:00
Core Insights - Matt Fitzpatrick won the 2025 DP World Tour Championship, marking his third title in this event and the 11th professional win of his career [1][2] - Protiviti, as Fitzpatrick's brand ambassador, donated 25,000 meals through its 'Birdies for Meals' campaign, which has provided over 700,000 meals since its inception in 2021 [1][4] Company Overview - Protiviti is a global consulting firm with expertise in various sectors, including finance, technology, and risk management, operating in over 25 countries [5] - The firm has been recognized on the Fortune 100 Best Companies to Work For list for 11 consecutive years and serves a significant portion of Fortune 100 and Fortune 500 companies [5]
flydubai inks deal with GE Aerospace for GEnx-1B engines and services to power its first widebody fleet
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation flydubai and GE Aerospace signed an agreement for 60 GEnx-1B engines to power the airline's new fleet of Boeing 787-9s. This agreement underpins flydubai's growth strategy and the continued expansion of its network, enabling the airline to increase capacity on existing routes, and meet demand from a growing passenger base. Established in 2008, flydubai has grown significantly, and currently serves more than 135 destinations across 57 countries; the airline is now addin ...
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation In his role on the SAB of NewcelX, Prof. Shefner will provide strategic guidance on the Company's programs in ALS, including the clinical development of AstroRx®, and will support the integration of neuromuscular and neurodegenerative disease expertise into the Company's broader platform of cell therapy and neuroscience innovation. ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or "the Company"), a clinical-stage bio ...